Question: what is the total value of rsus converted to bhge rsus , in millions?

def solution():
    # Define variables name and value
    number_of_rsus = 1.7
    value_per_rsu = 40.18

    # Do math calculation to get the answer
    answer = number_of_rsus * value_per_rsu

    return answer

Supplemental Financial Data We view net interest income and related ratios and analyses (i. e. , efficiency ratio and net interest yield) on a FTE basis.

Although these are non-GAAP measures, we believe managing the business with net interest income on a FTE basis provides a more accurate picture of the interest margin for comparative purposes.

To derive the FTE basis, net interest income is adjusted to reflect tax-exempt income on an equivalent before-tax basis with a corresponding increase in income tax expense.

For purposes of this calculation, we use the federal statutory tax rate of 35 percent.

This measure ensures comparability of net interest income arising from taxable and tax-exempt sources.

As mentioned above, certain per formance measures including the efficiency ratio and net interest yield utilize net interest income (and thus total revenue) on a FTE basis.

The efficiency ratio measures the costs expended to generate a dollar of revenue, and net interest yield evaluates how many basis points we are earning over the cost of funds.

During our annual planning process, we set efficiency targets for the Corporation and each line of business.

We believe the use of these non-GAAP measures provides additional clarity in assessing our results.

Targets vary by year and by business and are based on a variety of factors including maturity of the business, competitive environment, market factors and other items including our risk appetite.

We also evaluate our business based on the following ratios that utilize tangible equity, a non-GAAP measure.

Return on average tangible common shareholders’ equity measures our earnings contribution as a percentage of common shareholders’ equity plus any Common Equivalent Securities (CES) less goodwill and intangible assets, (excluding MSRs), net of related deferred tax liabilities.

ROTE measures our earnings contribution as a percentage of average shareholders’ equity less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities.

The tangible common equity ratio represents common shareholders’ equity plus any CES less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities divided by total assets less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities.

The tangible equity ratio represents total shareholders’ equity less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities divided by total assets less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities.

Tangible book value per common share represents ending common shareholders’ equity less goodwill and intangible assets (excluding MSRs), net of related deferred tax liabilities divided by ending common shares outstanding plus the number of common shares issued upon conversion of common equivalent shares.

These measures are used to evaluate our use of equity (i. e. , capital).

In addition, profitability, relationship and investment models all use ROTE as key measures to support our overall growth goals.

The aforementioned supplemental data and per formance measures are presented in Tables 6 and 7 and Statistical Tables XII and XIV.

In addition, in Table 7 and Statistical Table XIV, we have excluded the impact of goodwill impairment charges of $12.4 billion recorded in 2010 when presenting earnings and diluted earnings per common share, the efficiency ratio, return on average assets, return on average common shareholders’ equity, return on average tangible common shareholders’ equity and ROTE.

Accordingly, these are non-GAAP measures.

Statistical Tables XIII and XV provide reconciliations of these non-GAAP measures with financial measures defined by GAAP.

We believe the use of these non-GAAP measures provides additional clarity in assessing the results of the Corporation.

Other companies may define or calculate these measures and ratios differently

|(Dollars in millions, except per share information)|2010|2009|2008|2007|2006|
| Fully taxable-equivalent basis data||||||
|Net interest income|$52,693|$48,410|$46,554|$36,190|$35,818|
|Total revenue, net of interest expense|111,390|120,944|73,976|68,582|74,000|
|Net interest yield-1|2.78%|2.65%|2.98%|2.60%|2.82%|
|Efficiency ratio|74.61|55.16|56.14|54.71|48.37|
| Performance ratios, excluding goodwill impairment charges-2||||||
|Per common share information||||||
|Earnings|$0.87|||||
|Diluted earnings|0.86|||||
|Efficiency ratio|63.48%|||||
|Return on average assets|0.42|||||
|Return on average common shareholders’ equity|4.14|||||
|Return on average tangible common shareholders’ equity|7.03|||||
|Return on average tangible shareholders’ equity|7.11|||||

(1) Calculation includes fees earned on overnight deposits placed with the Federal Reserve of $368 million and $379 million for 2010 and 2009.

The Corporation did not have fees earned on overnight deposits during 2008, 2007 and 2006.

(2) Per formance ratios are calculated excluding the impact of goodwill impairment charges of $12.4 billion recorded during 2010.

Baker Hughes, a GE company Notes to Consolidated and Combined Financial Statements issuance pursuant to awards granted under the LTI Plan over its term which expires on the date of the annual meeting of the Company in 2027.

A total of 53.7 million shares of Class A common stock are available for issuance as of December 31, 2017.

As a result of the acquisition of Baker Hughes, on July 3, 2017, each outstanding Baker Hughes stock option was converted into an option to purchase a share of Class A common stock in the Company.

Consequently, we issued 6.8 million stock options which are fully vested.

Each converted option is subject to the same terms and conditions as applied to the original option, and the per share exercise price of each converted option was reduced by $17.50 to reflect the per share amount of the special dividend pursuant to the agreement associated with the Transactions.

Additionally, as a result of the acquisition of Baker Hughes, there were 1.7 million Baker Hughes restricted stock units (RSUs) that were converted to BHGE RSUs at a fair value of $40.18.

Stock-based compensation cost is measured at the date of grant based on the calculated fair value of the award and is generally recognized on a straight-line basis over the vesting period of the equity grant.

The compensation cost is determined based on awards ultimately expected to vest; therefore, we have reduced the cost for estimated forfeitures based on historical forfeiture rates.

Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods to reflect actual forfeitures.

There were no stock-based compensation costs capitalized as the amounts were not material.

During the year ended December 31, 2017, we issued 2.1 million RSUs and 1.6 million stock options under the LTI Plan.

These RSUs and stock options generally vest in equal amounts over a three-year vesting period provided that the employee has remained continuously employed by the Company through such vesting date.

Stock based compensation expense was $37 million in 2017.

Included in this amount is $15 million of expense which relates to the acceleration of equity awards upon termination of employment of Baker Hughes employees with change in control agreements, and are included as part of "Merger and related costs" in the consolidated and combined statements of income (loss).

As BHGE LLC is a pass through entity, any tax benefit would be recognized by its partners.

Due to its cumulative losses, BHGE is unable to recognize a tax benefit on its share of stock related expenses.

Stock Options The fair value of each stock option granted is estimated using the Black-Scholes option pricing model.

The following table presents the weighted average assumptions used in the option pricing model for options granted under the LTI Plan.

The expected life of the options represents the period of time the options are expected to be outstanding.

The expected life is based on a simple average of the vesting term and original contractual term of the awards.

The expected volatility is based on the historical volatility of our five main competitors over a six year period.

The risk-free interest rate is based on the observed U. S.  Treasury yield curve in effect at the time the options were granted.

The dividend yield is based on a five year history of dividend payouts in Baker Hughes.

||2017|
|Expected life (years)|6|
|Risk-free interest rate|2.1%|
|Volatility|36.4%|
|Dividend yield|1.2%|
|Weighted average fair value per share at grant date|$12.32|

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Fiscal years ended May 25, 2008, May 27, 2007, and May 28, 2006 Columnar Amounts in Millions Except Per Share Amounts The following table presents estimated future gross benefit payments and Medicare Part D subsidy receipts for the Company’s plans:

Certain employees of the Company are covered under defined contribution plans.

The expense related to these plans was $24.4 million, $22.9 million, and $25.9 million in fiscal 2008, 2007, and 2006, respectively.19.

RELATED PARTY TRANSACTIONS Sales to affiliates (equity method investees) of $4.2 million, $3.8 million, and $2.9 million for fiscal 2008, 2007, and 2006, respectively, are included in net sales.

The Company received management fees from affiliates of $16.3 million, $14.8 million, and $13.5 million in fiscal 2008, 2007, and 2006, respectively.

Accounts receivable from affiliates totaled $3.2 million and $2.5 million at May 25, 2008 and May 27, 2007, respectively, of which $3.0 million and $2.1 million are included in current assets held for sale, respectively.

Accounts payable to affiliates totaled $15.6 million and $13.5 million at May 25, 2008 and May 27, 2007, respectively.

During the first quarter of fiscal 2007, the Company sold an aircraft for proceeds of approximately $8.1 million to a company on whose board of directors one of the Company’s directors sits.

The Company recognized a gain of approximately $3.0 million on the transaction.

The Company leases various buildings that are beneficially owned by Opus Corporation or entities related to Opus Corporation (the “Opus Entities”).

The Opus Entities are affiliates or part of a large, national real estate development company.

A former member of the Company’s Board of Directors, who left the board in the second quarter of fiscal 2008, is a beneficial owner, officer and chairman of Opus Corporation, and a director or officer of the related entities.

The agreements relate to the leasing of land, buildings, and equipment for the Company in Omaha, Nebraska.

The Company occupies the buildings pursuant to long-term leases with Opus Corporation and other investors, and the leases contain various termination rights and purchase options.

The Company made rental payments of $13.5 million, $14.4 million, and $15.8 million in fiscal 2008, 2007, and 2006, respectively, to the Opus Entities.

The Company has also contracted with the Opus Entities for construction and property management services.

The Company made payments of $1.6 million, $2.8 million, and $3.0 million to the Opus Entities for these services in fiscal 2008, 2007, and 2006, respectively.20.  BUSINESS SEGMENTS AND RELATED INFORMATION The Company’s operations are organized into three reporting segments: Consumer Foods, Food and Ingredients, and International Foods.

The Consumer Foods reporting segment includes branded, private label, and customized food products which are sold in various retail and foodservice channels.

The products include a variety of categories (meals, entrees, condiments, sides, snacks, and desserts) across frozen, refrigerated, and

services revenue net of direct expenses reflecting higher financially reportable development revenue; and $65 million of stronger owned, leased, corporate housing and other revenue net of direct expenses.

The fee improvement versus the prior year also reflects the recognition in 2005 of $14 million of incentive fees that were calculated based on prior period results, but not earned and due until 2005.

The increase in owned, leased, corporate housing and other revenue net of direct expenses is primarily attributable to properties acquired in 2005, including the CTF properties, the strong demand environment in 2005, and our receipt in 2005, of a $10 million termination fee associated with one property that left our system.

The favorable items noted above were partially offset by $146 million of increased general and administrative expenses and $46 million of lower synthetic fuel revenue net of synthetic fuel expenses.

Increased general and administrative expenses were associated with our Lodging segments as unallocated general and administrative expenses were down slightly compared to the prior year.

The increase in general, administrative and other expenses reflects a $94 million pre-tax charge impacting our Full-Service Lodging segment, primarily due to the non-cash write-off of deferred contract acquisition costs associated with the termination of management agreements (discussed more fully later in this report in the “CTF Holdings Ltd. ” discussion under the “Investing Activities Cash Flows” caption in the “Liquidity and Capital Resources” section), and $30 million of pre-tax expenses associated with our bedding incentive program, impacting our Full-Service, Select-Service and Extended-Stay Lodging segments.

We implemented the bedding incentive program in 2005 to ensure that guests could enjoy the comfort and luxury of our new bedding by year-end 2005.

General and administrative expenses in 2005 also reflect pre-tax performance termination cure payments of $15 million associated with two properties, a $9 million pre-tax charge associated with three guarantees, increased other net overhead costs of $13 million including costs related to the Company’s unit growth, development and systems, and $2 million of increased foreign exchange losses partially offset by $5 million of lower litigation expenses.

Additionally, in 2004, general and administrative expenses included a $13 million charge associated with the write-off of deferred contract acquisition costs.

Operating income for 2005 includes a synthetic fuel operating loss of $144 million versus $98 million of operating losses in the prior year, reflecting increased costs and the consolidation of our synthetic fuel operations from the start of the 2004 second quarter, which resulted in the recognition of revenue and expenses for all of 2005 versus only three quarters in 2004, as we accounted for the synthetic fuel operations using the equity method of accounting in the 2004 first quarter.

For additional information, see our “Synthetic Fuel” segment discussion later in this report.2004 COMPARED TO 2003 Operating income increased $100 million to $477 million in 2004 from $377 million in 2003.

The increase is primarily due to higher fees, which are related both to stronger RevPAR, driven by increased occupancy and average daily rate, and to the growth in the number of rooms, and strong timeshare results, which are mainly attributable to strong demand and improved margins, partially offset by higher general and administrative expenses.

General, administrative and other expenses increased $84 million in 2004 to $607 million from $523 million in 2003, primarily reflecting higher administrative expenses in our Full-Service, Select-Service, and Extended-Stay segments ($55 million) and Timeshare segment ($24 million), primarily associated with increased overhead costs related to the Company’s unit growth and timeshare development, and a $10 million reduction in foreign exchange gains, offset by $6 million of lower litigation expenses.

Higher general and administrative expenses of $84 million also reflect a $13 million writeoff of deferred contract acquisition costs as further discussed in the “2004 Compared to 2003” caption under the “Select-Service Lodging” heading later in this report.

Gains and Other Income The following table shows our gains and other income for 2005, 2004, and 2003.

Answer: 68.306


Question: What is the total amount of Corporate notes and bonds of 2010 Fair Value, and Net sales of 2011 ?

def solution():
    # Define variables name and value
    corporate_notes_and_bonds_2010_fair_value = 1133.0
    net_sales_2011 = 9381.0

    # Do math calculation to get the answer
    answer = corporate_notes_and_bonds_2010_fair_value + net_sales_2011

    return answer

Aeronautics’ operating profit for 2012 increased $69 million, or 4%, compared to 2011.

The increase was attributable to higher operating profit of approximately $105 million from C-130 programs due to an increase in risk retirements; about $50 million from F-16 programs due to higher aircraft deliveries partially offset by a decline in risk retirements; approximately $50 million from F-35 production contracts due to increased production volume and risk retirements; and about $50 million from the completion of purchased intangible asset amortization on certain F-16 contracts.

Partially offsetting the increases was lower operating profit of about $90 million from the F-35 development contract primarily due to the inception-to-date effect of reducing the profit booking rate in the second quarter of 2012; approximately $50 million from decreased production volume and risk retirements on the F-22 program partially offset by a resolution of a contractual matter in the second quarter of 2012; and approximately $45 million primarily due to a decrease in risk retirements on other sustainment activities partially offset by various other Aeronautics programs due to increased risk retirements and volume.

Operating profit for C-5 programs was comparable to 2011.

Adjustments not related to volume, including net profit booking rate adjustments and other matters described above, were approximately $30 million lower for 2012 compared to 2011.

Backlog Backlog decreased in 2013 compared to 2012 mainly due to lower orders on F-16, C-5, and C-130 programs, partially offset by higher orders on the F-35 program.

Backlog decreased in 2012 compared to 2011 mainly due to lower orders on F-35 and C-130 programs, partially offset by higher orders on F-16 programs.

Trends We expect Aeronautics’ net sales to increase in 2014 in the mid-single digit percentage range as compared to 2013 primarily due to an increase in net sales from F-35 production contracts.

Operating profit is expected to increase slightly from 2013, resulting in a slight decrease in operating margins between the years due to program mix.

Information Systems & Global Solutions Our IS&GS business segment provides advanced technology systems and expertise, integrated information technology solutions, and management services across a broad spectrum of applications for civil, defense, intelligence, and other government customers.

IS&GS has a portfolio of many smaller contracts as compared to our other business segments.

IS&GS has been impacted by the continued downturn in federal information technology budgets.

IS&GS’ operating results included the following (in millions):

2013 compared to 2012 IS&GS’ net sales decreased $479 million, or 5%, for 2013 compared to 2012.

The decrease was attributable to lower net sales of about $495 million due to decreased volume on various programs (command and control programs for classified customers, NGI, and ERAM programs); and approximately $320 million due to the completion of certain programs (such as Total Information Processing Support Services, the Transportation Worker Identification Credential (TWIC), and ODIN).

The decrease was partially offset by higher net sales of about $340 million due to the start-up of certain programs (such as the DISA GSM-O and the National Science Foundation Antarctic Support).

IS&GS’ operating profit decreased $49 million, or 6%, for 2013 compared to 2012.

The decrease was primarily attributable to lower operating profit of about $55 million due to certain programs nearing the end of their lifecycles, partially offset by higher operating profit of approximately $15 million due to the start-up of certain programs.

Adjustments not related to volume, including net profit booking rate adjustments and other matters, were comparable for 2013 compared to 2012.2012 compared to 2011 IS&GS’ net sales for 2012 decreased $535 million, or 6%, compared to 2011.

The decrease was attributable to lower net sales of approximately $485 million due to the substantial completion of various programs during 2011 (primarily JTRS; ODIN; and U. K.  Census); and about $255 million due to lower volume on numerous other programs (primarily Hanford;

The table below provides information on the location and pretax gain or loss amounts for derivatives that are: (i) designated in a fair value hedging relationship, (ii) designated in a cash flow hedging relationship, (iii) designated in a foreign currency net investment hedging relationship and (iv) not designated in a hedging relationship

|Years Ended December 31|2011|2010|
|Derivatives designated in fair value hedging relationships|||
|Interest rate swap contracts|||
|Amount of gain recognized inOther (income) expense, neton derivatives|$-196|$-23|
|Amount of loss recognized inOther (income) expense, neton hedged item|196|23|
|Derivatives designated in foreign currency cash flow hedging relationships|||
|Foreign exchange contracts|||
|Amount of loss reclassified fromAOCItoSales|85|7|
|Amount of loss (gain) recognized inOCIon derivatives|143|-103|
|Derivatives designated in foreign currency net investment hedging relationships|||
|Foreign exchange contracts|||
|Amount of gain recognized inOther (income) expense, netonderivatives(1)|-10|-1|
|Amount of loss recognized inOCIon deriviatives|122|24|
|Derivatives not designated in a hedging relationship|||
|Foreign exchange contracts|||
|Amount of gain recognized inOther (income) expense, netonderivatives(2)|-113|-33|
|Amount of gain recognized inSales|—|-81|

(1) There was no ineffectiveness on the hedge.

Represents the amount excluded from hedge effectiveness testing.

(2) These derivative contracts mitigate changes in the value of remeasured foreign currency denominated monetary assets and liabilities attributable to changes in foreign currency exchange rates.

At December 31, 2011, the Company estimates $18 million of pretax net unrealized losses on derivatives maturing within the next 12 months that hedge foreign currency denominated sales over that same period will be reclassified from AOCI to Sales.

The amount ultimately reclassified to Sales may differ as foreign exchange rates change.

Realized gains and losses are ultimately determined by actual exchange rates at maturity.

Investments in Debt and Equity Securities Information on available-for-sale investments at December 31 is as follows:

Available-for-sale debt securities included in Short-term investments totaled $1.4 billion at December 31, 2011.

Of the remaining debt securities, $2.9 billion mature within five years.

At December 31, 2011, there were no debt securities pledged as collateral.

The table below provides a summary of the changes in fair value of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

|Years Ended December 31|2011|2010|
|Beginning balance January 1|$13|$72|
|Sales|-13|-67|
|Total realized and unrealized gains (losses)Included in:|||
|Earnings-1|—|18|
|Comprehensive income|—|-10|
|Ending balance December 31|$—|$13|
|Losses recorded in earnings for Level 3 assets still held atDecember 31|$—|$—|

(1) Amounts are recorded in Other (income) expense, net.

Financial Instruments Not Measured at Fair Value Some of the Company’s financial instruments are not measured at fair value on a recurring basis but are recorded at amounts that approximate fair value due to their liquid or short-term nature, such as cash and cash equivalents, receivables and payables.

The estimated fair value of loans payable and long-term debt (including current portion) at December 31, 2011 was $19.5 billion compared with a carrying value of $17.5 billion and at December 31, 2010 was $18.7 billion compared with a carrying value of $17.9 billion.

Fair value was estimated using quoted dealer prices.

Concentrations of Credit Risk On an ongoing basis, the Company monitors concentrations of credit risk associated with corporate and government issuers of securities and financial institutions with which it conducts business.

Credit exposure limits are established to limit a concentration with any single issuer or institution.

Cash and investments are placed in instruments that meet high credit quality standards, as specified in the Company’s investment policy guidelines.

Approximately three-quarters of the Company’s cash and cash equivalents are invested in three highly rated money market funds.

The majority of the Company’s accounts receivable arise from product sales in the United States and Europe and are primarily due from drug wholesalers and retailers, hospitals, government agencies, managed health care providers and pharmacy benefit managers.

The Company monitors the financial performance and creditworthiness of its customers so that it can properly assess and respond to changes in their credit profile.

The Company also continues to monitor economic conditions, including the volatility associated with international sovereign economies, and associated impacts on the financial markets and its business, taking into consideration the global economic downturn and the sovereign debt issues in certain European countries.

The Company continues to monitor the credit and economic conditions within Greece, Spain, Italy and Portugal, among other members of the EU.

These deteriorating economic conditions, as well as inherent variability of timing of cash receipts, have resulted in, and may continue to result in, an increase in the average length of time that it takes to collect accounts receivable outstanding.

As such, time value of money discounts have been recorded for those customers for which collection of accounts receivable is expected to be in excess of one year.

The Company does not expect to have write-offs or adjustments to accounts receivable which would have a material adverse effect on its financial position, liquidity or results of operations.

As of December 31, 2011, the Company’s accounts receivable in Greece, Italy, Spain and Portugal totaled approximately $1.6 billion.

Of this amount, hospital and public sector receivables were approximately $1.1 billion in the aggregate, of which approximately 8%, 36%, 47% and 9% related to Greece, Italy, Spain and Portugal, respectively.

As of December 31, 2011, the Company’s total accounts receivable outstanding for more than one year were approximately $400 million, of which approximately 90% related to accounts receivable in Greece, Italy, Spain and Portugal, mostly comprised of hospital and public sector receivables.

Other Animal Health Animal Health includes pharmaceutical and vaccine products for the prevention, treatment and control of disease in all major farm and companion animal species.

Animal Health sales are affected by intense competition and the frequent introduction of generic products.

Global sales of Animal Health products grew 11% in 2011 to $3.3 billion from $2.9 billion in 2010.

Foreign exchange favorably affected global sales performance by 3% in 2011.

The increase in sales was driven by positive performance among cattle, swine, poultry and companion animal products.

Global sales of Animal Health products were $494 million for the post-Merger period in 2009.

Consumer Care Consumer Care products include over-the-counter, foot care and sun care products such as Claritin non-drowsy antihistamines; Dr.  Scholl’s foot care products; Coppertone sun care products; and MiraLAX, a treatment for occasional constipation.

Global sales of Consumer Care products increased 1% in 2011 to $1.8 billion reflecting strong performance of Coppertone, offset by declines in Dr.  Scholl’s and Claritin.

Consumer Care product sales were $149 million for the post-Merger period in 2009.

Consumer Care product sales are affected by competition and consumer spending patterns.

Alliances AstraZeneca has an option to buy Merck’s interest in a subsidiary, and through it, Merck’s interest in Nexium and Prilosec, exercisable in 2012, and the Company believes that it is likely that AstraZeneca will exercise that option (see “Selected Joint Venture and Affiliate Information” below).

If AstraZeneca exercises its option, the Company will no longer record equity income from AZLP and supply sales to AZLP will decline substantially.

Answer: 10514.0


Question: What was the average value of Service cost, Interest cost, Employer contributions in 2015 for Pension Benefits? (in million)

def solution():
    # Define variables name and value
    service_cost = 150
    interest_cost = 242
    employer_contributions = 103
    const_3 = 3

    # Do math calculation to get the answer
    average_value = (service_cost + interest_cost + employer_contributions) / const_3

    return average_value

The funded status of the Company's plans as of December 31, 2015 and 2014, was as follows

||Pension Benefits December 31|Other Benefits December 31|
|($ in millions)|2015|2014|2015|2014|
|Change in Benefit Obligation|||||
|Benefit obligation at beginning of year|$5,671|$4,730|$650|$616|
|Service cost|150|136|13|13|
|Interest cost|242|253|27|30|
|Plan participants' contributions|11|26|6|7|
|Actuarial loss (gain)|-254|714|-91|24|
|Benefits paid|-185|-168|-39|-40|
|Curtailments|—|-20|—|—|
|Benefit obligation at end of year|5,635|5,671|566|650|
|Change in Plan Assets|||||
|Fair value of plan assets at beginning of year|4,731|4,310|—|—|
|Actual return on plan assets|-47|437|—|—|
|Employer contributions|103|126|33|33|
|Plan participants' contributions|11|26|6|7|
|Benefits paid|-185|-168|-39|-40|
|Fair value of plan assets at end of year|4,613|4,731|—|—|
|Funded status|$-1,022|$-940|$-566|$-650|
|Amounts Recognized in the Consolidated Statements of Financial Position:|||||
|Pension plan assets|$—|$17|$—|$—|
|Current liability-1|-21|-18|-143|-143|
|Non-current liability-2|-1,001|-939|-423|-507|
|Accumulated other comprehensive loss (income) (pre-tax) related to:|||||
|Prior service costs (credits)|86|105|-105|-125|
|Net actuarial loss (gain)|1,433|1,374|-21|73|

(1) Included in other current liabilities and current portion of postretirement plan liabilities, respectively.

(2) Included in pension plan liabilities and other postretirement plan liabilities, respectively.

The Projected Benefit Obligation ("PBO"), Accumulated Benefit Obligation ("ABO"), and asset values for the Company's qualified pension plans were $5,490 million, $5,146 million, and $4,613 million, respectively, as of December 31, 2015, and $5,529 million, $5,124 million, and $4,731 million, respectively, as of December 31, 2014.

The PBO represents the present value of pension benefits earned through the end of the year, with allowance for future salary increases.

The ABO is similar to the PBO, but does not provide for future salary increases.

The PBO and fair value of plan assets for all qualified and non-qualified pension plans with PBOs in excess of plan assets were $5,635 million and $4,613 million, respectively, as of December 31, 2015, and $4,394 million and $3,438 million, respectively, as of December 31, 2014.

The ABO and fair value of plan assets for all qualified and non-qualified pension plans with ABOs in excess of plan assets were $4,051 million and $3,391 million, respectively, as of December 31, 2015, and $3,981 million and $3,438 million, respectively, as of December 31, 2014.

The ABO for all pension plans was $5,273 million and $5,244 million as of December 31, 2015 and 2014, respectively.

The changes in amounts recorded in accumulated other comprehensive income (loss) were as follows:

FAS/CAS Adjustment The FAS/CAS Adjustment represents the difference between our pension and postretirement plan expense under FAS and under CAS.

2015 - The FAS/CAS Adjustment in 2015 was a net benefit of $104 million, compared to a net benefit of $72 million in 2014.

The favorable change was driven by the phase-in of Harmonization and better than expected 2014 asset returns, partially offset by higher FAS expense primarily due to lower discount rates at the end of 2014.2014 - The FAS/CAS Adjustment in 2014 was a net benefit of $72 million, compared to a net expense of $61 million in 2013.

The favorable change was driven by lower FAS expense, due primarily to higher discount rates and plan assets at the end of 2013, the full year effect of the 2013 postretirement benefits amendment, and the phase-in of Harmonization.

We expect the FAS/CAS Adjustment in 2016 to be a net benefit of approximately $137 million ($161 million FAS and $298 million CAS), primarily driven by the continued phase-in of Harmonization and higher FAS discount rates, partially offset by lower than expected 2015 asset returns.

The expected FAS/CAS Adjustment is subject to change during 2016, when we remeasure our actuarial estimate of the unfunded benefit obligation for CAS with updated census data and other items.

Deferred State Income Taxes Deferred state income taxes reflect the change in deferred state tax assets and liabilities in the relevant period.

These amounts are recorded within operating income, while the current period state income tax expense is charged to contract costs and included in cost of sales and service revenues in segment operating income.2015 - The deferred state income tax expense remained constant at $2 million in 2015 and 2014.

Deferred state tax expense in 2015 was primarily attributable to changes in the timing of contract taxable income and pension related adjustments, partially offset by a reduction in the valuation allowance for state tax credit carryforwards.2014 - The deferred state income tax expense in 2014 was $2 million, compared to a benefit of $6 million in 2013.

This change was primarily attributable to non-recurring adjustments related to establishing a valuation allowance for a state tax loss carryforward and the true-up of 2013 deferred taxes.

These increases were partially offset by changes in the timing of contract taxable income and reserves that are not currently deductible for tax purposes.

Interest Expense 2015 - Interest expense in 2015 was $137 million, compared to $149 million in 2014.

The decrease was primarily a result of refinancing 6.875% senior notes with 5.000% senior notes and repayment in full of the term loans, partially offset by loss on early extinguishment of debt.

See Note 14: Debt in Item 8.2014 - Interest expense in 2014 was $149 million, compared to $118 million in 2013.

The increase was primarily a result of a loss on the early extinguishment of debt in the fourth quarter of 2014.

Federal Income Taxes 2015 - Our effective tax rate on earnings from continuing operations was 36.1% in 2015, compared to 33.3% in 2014.

The increase in our effective tax rate for 2015 was primarily attributable to adjustments to the domestic manufacturing deduction and an increase in the goodwill impairment that is not amortizable for tax purposes.

Advance Payments and Billings in Excess of Revenues - Payments received in excess of inventoried costs and revenues are recorded as advance payment liabilities.

Property, Plant, and Equipment - Depreciable properties owned by the Company are recorded at cost and depreciated over the estimated useful lives of individual assets.

Major improvements are capitalized while expenditures for maintenance, repairs, and minor improvements are expensed.

Costs incurred for computer software developed or obtained for internal use are capitalized and amortized over the expected useful life of the software, not to exceed nine years.

Leasehold improvements are amortized over the shorter of their useful lives or the term of the lease.

The remaining assets are depreciated using the straight-line method, with the following lives:

||Years|
|Land improvements|3|-|40|
|Buildings and improvements|3|-|60|
|Capitalized software costs|3|-|9|
|Machinery and other equipment|2|-|45|

The Company evaluates the recoverability of its property, plant, and equipment when there are changes in economic circumstances or business objectives that indicate the carrying value may not be recoverable.

The Company's evaluations include estimated future cash flows, profitability, and other factors affecting fair value.

As these assumptions and estimates may change over time, it may or may not be necessary to record impairment charges.

Leases - The Company uses its incremental borrowing rate in the assessment of lease classification as capital or operating and defines the initial lease term to include renewal options determined to be reasonably assured.

The Company conducts operations primarily under operating leases.

Many of the Company's real property lease agreements contain incentives for tenant improvements, rent holidays, or rent escalation clauses.

For incentives for tenant improvements, the Company records a deferred rent liability and amortizes the deferred rent over the term of the lease as a reduction to rent expense.

For rent holidays and rent escalation clauses during the lease term, the Company records minimum rental expenses on a straight-line basis over the term of the lease.

For purposes of recognizing lease incentives, the Company uses the date of initial possession as the commencement date, which is generally the date on which the Company is given the right of access to the space and begins to make improvements in preparation for the intended use.

Goodwill and Other Intangible Assets - The Company performs impairment tests for goodwill as of November 30 of each year and between annual impairment tests if evidence of potential impairment exists, by first comparing the carrying value of net assets to the fair value of the related operations.

If the fair value is determined to be less than the carrying value, a second step is performed to determine if goodwill is impaired, by comparing the estimated fair value of goodwill to its carrying value.

Purchased intangible assets are amortized on a straight-line basis or a method based on the pattern of benefits over their estimated useful lives, and the carrying value of these assets is reviewed for impairment when events indicate that a potential impairment may have occurred.

Equity Method Investments - Investments in which the Company has the ability to exercise significant influence over the investee but does not own a majority interest or otherwise control are accounted for under the equity method of accounting and included in other assets in its consolidated statements of financial position.

The Company's equity investments align strategically and are integrated with the Company's operations, and therefore the Company's share of the net earnings or losses of the investee is included in operating income (loss).

The Company evaluates its equity investments for other than temporary impairment whenever events or changes in business circumstances indicate that the carrying amounts of such investments may not be fully recoverable.

If a decline in the value of an equity method investment is determined to be other than temporary, a loss is recorded in earnings in the current period.

Self-Insured Group Medical Insurance - The Company maintains a self-insured group medical insurance plan.

The plan is designed to provide a specified level of coverage for employees and their dependents.

Answer: 165.0


Question: percent change of average shares outstanding when taking dilution into consideration in 2008?

def solution():
    # Define variables name and value
    weighted_average_shares_diluted = 228.3
    weighted_average_shares_basic = 227.3

    # Do math calculation to get the answer
    answer = ((weighted_average_shares_diluted / weighted_average_shares_basic) - 1) * 100

    return answer

ABIOMED, INC.  AND SUBSIDIARIES Notes to Consolidated Financial Statements—(Continued) Note 12.

Stock Award Plans and Stock Based Compensation (Continued) Restricted Stock The following table summarizes restricted stock activity for the fiscal year ended March 31, 2009:

|| March 31, 2009|
||Number of Shares (in thousands)| Grant Date Fair Value|
|Restricted stock awards at March 31, 2008|54|$11.52|
|Granted|666|16.75|
|Vested|-167|14.65|
|Forfeited|-73|17.53|
|Restricted stock awards at March 31, 2009|480|$16.77|

The remaining unrecognized compensation expense for restricted stock awards at March 31, 2009 was $4.6 million.

The weighted average remaining contractual life for restricted stock awards at March 31, 2009 and 2008 was 1.8 and 2.4 years, respectively.

In May 2008, 260,001 shares of restricted stock were issued to certain executive officers and certain members of senior management of the Company, of which 130,002 of these shares vest upon achievement of a prescribed performance milestone.

In September 2008, the Company met the prescribed performance milestone, and all of these performance-based shares vested.

In connection with the vesting of these shares, these employees paid withholding taxes due by returning 39,935 shares valued at $0.7 million.

These shares have been recorded as treasury stock as of March 31, 2009.

The remaining 129,999 of the restricted shares award vest ratably over four years from the grant date.

The stock compensation expense for the restricted stock awards is recognized on a straight-line basis over the vesting period, based on the probability of achieving the performance milestones.

In August 2008, 406,250 shares of restricted stock were issued to certain executive officers and certain members of senior management of the Company, all of which could vest upon achievement of certain prescribed performance milestones.

In March 2009, the Company met a prescribed performance milestone, and a portion of these performance-based shares vested.

The remaining stock compensation expense for the restricted stock awards is being recognized on a straight-line basis over the vesting period through March 31, 2011 based on the probability of achieving the performance milestones.

The cumulative effects of changes in the probability of achieving the milestones will be recorded in the period in which the changes occur.

During the year ended March 31, 2008, 60,000 shares of restricted stock were issued to certain executive officers of the Company that vest on the third anniversary of the date of grant.

The stock compensation expense for the restricted stock awards is recognized on a straight-line basis over the vesting period.

Employee Stock Purchase Plan In March 1988, the Company adopted the 1988 Employee Stock Purchase Plan (“the Purchase Plan” or “ESPP”), as amended.

Under the Purchase Plan, eligible employees, including officers and directors, who have completed three months of employment with the Company or its subsidiaries who elect to participate in the Purchase plan instruct the Company to withhold a specified amount from each payroll period during a six-month payment period (the periods April 1—September 30 and October 1—March 31).

On the last business day of each payment period, the amount withheld is used to purchase common stock at an exercise price equal to 85% of the lower of its market price on the first business day or the last business day of the payment period.

Up to 500,000 shares of common stock may be issued under the Purchase Plan, of which 163,245 shares are available for future issuance as of March 31, 2009.

During the years ended March 31, 2009, 2008 and 2007, 45,823, 23,930, and 27,095 shares of common stock, respectively, were sold pursuant to the Purchase Plan.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information Our common stock is traded on the New York Stock Exchange under the ticker symbol BBY.

The table below sets forth the high and low sales prices of our common stock as reported on the New York Stock Exchange — Composite Index during the periods indicated.

The stock prices below have been revised to reflect a three-for-two stock split effected on August 3, 2005.

Holders As of April 24, 2006, there were 2,632 holders of record of Best Buy common stock.

Dividends In fiscal 2004, our Board initiated the payment of a regular quarterly cash dividend, then $0.07 per common share per quarter.

A quarterly cash dividend has been paid in each subsequent quarter.

Effective with the quarterly cash dividend paid in the third quarter of fiscal 2005, we increased our quarterly cash dividend per common share by 10 percent.

Effective with the quarterly cash dividend paid in the third quarter of fiscal 2006, we increased our quarterly cash dividend per common share by 9 percent to $0.08 per common share per quarter.

The payment of cash dividends is subject to customary legal and contractual restrictions.

Future dividend payments will depend on the Company’s earnings, capital requirements, financial condition and other factors considered relevant by our Board.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers In April 2005, our Board authorized a $1.5 billion share repurchase program.

The program, which became effective on April 27, 2005, terminated and replaced a $500 million share repurchase program authorized by our Board in June 2004.

Effective on June 24, 2004, our Board authorized the $500 million share repurchase program, which terminated and replaced a $400 million share repurchase program authorized by our Board in fiscal 2000.

During the fourth quarter of fiscal 2006, we purchased and retired 7.1 million shares at a cost of $338 million.

Since the inception of the $1.5 billion share repurchase program in fiscal 2006, we purchased and retired 16.5 million shares at a cost of $711 million.

We consider several factors in determining when to make share repurchases including, among other things, our cash needs and the market price of the stock.

At the end of fiscal 2006, $790 million of the $1.5 billion originally authorized by our Board was available for future share repurchases.

Cash provided by future operating activities, available cash and cash equivalents, as well as short-term investments, are the expected sources of funding for the share repurchase program.

Management’s Discussion and Analysis of Financial Condition and Results of Operations – Continued Con Edison’s principal business segments are CECONY’s regulated utility activities, O&R’s regulated utility activities and Con Edison’s competitive energy businesses.

CECONY’s principal business segments are its regulated electric, gas and steam utility activities.

A discussion of the results of operations by principal business segment for the years ended December 31, 2014, 2013 and 2012 follows.

For additional business segment financial information, see Note N to the financial statements in Item 8.

Year Ended December 31, 2014 Compared with Year Ended December 31, 2013 The Companies’ results of operations in 2014 compared with 2013 were:

||CECONY|O&R|Competitive Energy Businesses|Other(a)|Con Edison(b)|
| (Millions of Dollars)|Increases (Decreases) Amount|Increases (Decreases) Percent|Increases (Decreases) Amount|Increases (Decreases) Percent|Increases (Decreases) Amount|Increases (Decreases) Percent|Increases (Decreases) Amount|Increases (Decreases) Percent|Increases (Decreases) Amount|Increases (Decreases) Percent|
|Operating revenues|$356|3.4%|$59|7.1%|$148|13.5%|$2|40.0%|$565|4.6%|
|Purchased power|70|3.5|21|9.7|227|26.4|-|-|318|10.3|
|Fuel|-35|-10.9|-|-|-|-|-|-|-35|-10.9|
|Gas purchased for resale|77|14.5|12|15.8|88|Large|-1|Large|176|27.7|
|Other operations and maintenance|138|5.0|16|5.3|3|2.9|-|-|157|5.0|
|Depreciation and amortization|45|4.8|5|8.9|-4|-17.4|1|Large|47|4.6|
|Taxes, other than income taxes|-18|-1.0|-2|-3.2|2|11.8|-|-|-18|-0.9|
|Gain on sale of solar electric production projects|-|-|-|-|45|-|-|-|45|-|
|Operating income (loss)|79|3.8|7|5.8|-123|Large|2|Large|-35|-1.6|
|Other income less deductions|10|Large|2|Large|20|Large|-3|Large|29|Large|
|Net interest expense|16|3.1|-2|-5.4|-143|Large|1|3.8|-128|-17.8|
|Income before income tax expense|73|4.7|11|13.1|40|62.5|-2|-9.1|122|7.9|
|Income tax expense|35|6.7|16|84.2|34|82.9|7|31.8|92|19.3|
|Net income for common stock|$38|3.7%|$-5|-7.7%|$6|26.1%|$-9|Large|$30|2.8%|

(a) Includes parent company and consolidation adjustments.

(b) Represents the consolidated financial results of Con Edison and its businesses.

reasonably possible that such matters will be resolved in the next twelve months, but we do not anticipate that the resolution of these matters would result in any material impact on our results of operations or financial position.

Foreign jurisdictions have statutes of limitations generally ranging from 3 to 5 years.

Years still open to examination by foreign tax authorities in major jurisdictions include Australia (2003 onward), Canada (2002 onward), France (2006 onward), Germany (2005 onward), Italy (2005 onward), Japan (2002 onward), Puerto Rico (2005 onward), Singapore (2003 onward), Switzerland (2006 onward) and the United Kingdom (2006 onward).

Our tax returns are currently under examination in various foreign jurisdictions.

The most significant foreign tax jurisdiction under examination is the United Kingdom.

It is reasonably possible that such audits will be resolved in the next twelve months, but we do not anticipate that the resolution of these audits would result in any material impact on our results of operations or financial position.13.

CAPITAL STOCK AND EARNINGS PER SHARE We are authorized to issue 250 million shares of preferred stock, none of which were issued or outstanding as of December 31, 2008.

The numerator for both basic and diluted earnings per share is net earnings available to common stockholders.

The denominator for basic earnings per share is the weighted average number of common shares outstanding during the period.

The denominator for diluted earnings per share is weighted average shares outstanding adjusted for the effect of dilutive stock options and other equity awards.

The following is a reconciliation of weighted average shares for the basic and diluted share computations for the years ending December 31 (in millions):

||2008|2007|2006|
|Weighted average shares outstanding for basic net earnings per share|227.3|235.5|243.0|
|Effect of dilutive stock options and other equity awards|1.0|2.0|2.4|
|Weighted average shares outstanding for diluted net earnings per share|228.3|237.5|245.4|

For the year ended December 31, 2008, an average of 11.2 million options to purchase shares of common stock were not included in the computation of diluted earnings per share as the exercise prices of these options were greater than the average market price of the common stock.

For the years ended December 31, 2007 and 2006, an average of 3.1 million and 7.6 million options, respectively, were not included.

During 2008, we repurchased approximately 10.8 million shares of our common stock at an average price of $68.72 per share for a total cash outlay of $737.0 million, including commissions.

In April 2008, we announced that our Board of Directors authorized a $1.25 billion share repurchase program which expires December 31, 2009.

Approximately $1.13 billion remains authorized under this plan.14.

SEGMENT DATA We design, develop, manufacture and market orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products which include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation.

We also provide other healthcare-related services.

Revenue related to these services currently represents less than 1 percent of our total net sales.

We manage operations through three major geographic segments – the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised primarily of Japan and includes other Asian and Pacific markets.

This structure is the basis for our reportable segment information discussed below.

Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based compensation expense, settlement, certain claims, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense.

Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U. S.  and Puerto Rico-based manufacturing operations and logistics.

Intercompany transactions have been eliminated from segment operating profit.

Management reviews accounts receivable, inventory, property, plant and equipment, goodwill and intangible assets by reportable segment exclusive of U.

S and Puerto Rico-based manufacturing operations and logistics and corporate assets.

Answer: 0.439947206335245


Question: What's the total amount of the 3-Year term loan in 2017 in the years where North America is greater than 300 ?

def solution():
    # Define variables name and value
    three_year_term_loan_2017 = 1950000

    # Do math calculation to get the answer
    answer = three_year_term_loan_2017 + three_year_term_loan_2017

    return answer

ANALOG DEVICES, INC.  NOTES TO CONSOLIDATED FINANCIALSTATEMENTS-(Continued)

k.  Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure f of contingencies at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.

Such estimates relate to the useful lives of fixed assets, identified intangible assets allowances for doubtful accounts and customer returns, the net realizable value of inventory, potential reserves relating to litigation matters, accrued liabilities, y accrued taxes, deferred tax valuation allowances, assumptions pertaining to share-based payments, and fair value of acquired assets and liabilities, including inventoryy, propertyy, plant and equipment and acquired intangibles, and other reserves.

Actual results could differ from those estimates and such dif f ferences may be material to the financial statements.

f l.  Concentrations of Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of investments and trade accounts receivable.

The Company maintains cash, cash equivalents and short-term and long-term investments with high credit quality counterparties, continuously monitors the amount of credit exposure to any one issuer and diversifies its investments in order to minimize its credit risk.

The Company sells its products to distributors and original equipment manufacturers involved in a variety of industries including industrial process automation, instrumentation, defense/aerospace, automotive, communications, computers and computer peripherals and consumer electronics.

The Company has adopted credit policies and standards to accommodate growth in these markets.

The Company performs continuing credit evaluations of its customers’ financial condition and although the Company generally does not require collateral, the Company may require letters of credit from customers in certain circumstances.

The Company provides reserves for estimated amounts of accounts receivable that may not be collected.

The Company's largest single end customer represented approximately14%, 12% and 13% of total revenue in fiscal years 2017, 2016 and 2015, respectively.

m.  Concentration of Other Risks The semiconductor industry is characterized by rapid technological change, competitive pricing pressures and cyclical market patterns.

The Company’s financial results are affected by a wide variety of factors, including general economic f conditions worldwide, economic conditions specific to the semiconductor industry, the timely implementation of new y manufacturing technologies, the ability to safeguard patents and intellectual property in a rapidly evolving market and reliance on assembly and test subcontractors, third-party wafer fabricators and independent distributors.

In addition, the semiconductor market has historically been cyclical and subject to significant economic downturns at various times.

The Company is exposed to the risk of obsolescence of its inventory depending on the mix of future business.

Additionallyy, a large portion of the Company’s purchases of external wafer and foundry services are from a limited number of suppliers, primarily Taiwan T Semiconductor Manufacturing Company (TSMC).

If TSMC or any of the Company’s other key suppliers are unable or unwilling to manufacture and deliver suffficient quantities of components, on the time schedule and of the quality that the Company requires, the Company may be forced to engage additional or replacement suppliers, which could result in significant expenses and disruptions or delays in manufacturing, product development and shipment of product to the Company’s

Warranties and Indemnities The Company generally warrants that its products sold to its customers will conform to the Company’s approved specifications and be free from defects in material and workmanship under normal use and service for one year.

Subject to certain exceptions, the Company also offers a three-year limited warranty to end users for only those CPU and AMD A-Series APU products that are commonly referred to as “processors in a box” and for PC workstation products.

The Company has also offered extended limited warranties to certain customers of “tray” microprocessor products and/or workstation graphics products who have written agreements with the Company and target their computer systems at the commercial and/or embedded markets.

Changes in the Company’s estimated liability for product warranty during the years ended December 28, 2013 and December 29, 2012 are as follows:

||December 28, 2013|December 29, 2012|
||(In millions)|
|Beginning balance|$16|$20|
|New warranties issued during the period|27|28|
|Settlements during the period|-25|-30|
|Changes in liability for pre-existing warranties during the period, includingexpirations|-1|-2|
|Ending balance|$17|$16|

In addition to product warranties, the Company, from time to time in its normal course of business, indemnifies other parties, with whom it enters into contractual relationships, including customers, lessors and parties to other transactions with the Company, with respect to certain matters.

In these limited matters, the Company has agreed to hold certain third parties harmless against specific types of claims or losses, such as those arising from a breach of representations or covenants, third-party claims that the Company’s products when used for their intended purpose(s) and under specific conditions infringe the intellectual property rights of a third party, or other specified claims made against the indemnified party.

It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision.

Historically, payments made by the Company under these obligations have not been material.

NOTE 17: Contingencies Securities Class Action On January 15, 2014, a class action lawsuit captioned Hatamian v.  AMD, et al.

No.3:14-cv-00226 was filed against the Company in the United States District Court for the Northern District of California.

The complaint purports to assert claims against the Company and certain individual officers for alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule 10b-5 of the Exchange Act.

The plaintiff seeks to represent a proposed class of all persons who purchased or otherwise acquired AMD common stock during the period October 27, 2011 through October 28, 2012.

The complaint seeks damages allegedly caused by alleged materially misleading statements and/or material omissions by the Company and the individual officers regarding our 32nm technology and “Llano” product, which statements and omissions, the plaintiffs claim, allegedly operated to inflate artificially the price paid for AMD’s common stock during the period.

The complaint seeks unspecified compensatory damages, attorneys’ fees and costs.

Based upon information presently known to the Company’s management, the Company believes that the potential liability, if any, will not have a material adverse effect on our financial condition, cash flows or results of operations.

GUR is an engineered material used in heavy-duty automotive and industrial applications such as car battery separator panels and industrial conveyor belts, as well as in specialty medical and consumer applications, such as sports equipment and prostheses.

GUR micro powder grades are used for high-performance filters, membranes, diagnostic devices, coatings and additives for thermoplastics and elastomers.

GUR fibers are also used in protective ballistic applications.

Celstran and Compel are long fiber reinforced thermoplastics, which impart extra strength and stiffness, making them more suitable for larger parts than conventional thermoplastics.

Polyesters such as Celanex PBT, Vandar, a series of PBT-polyester blends and Riteflex, a thermoplastic polyester elastomer, are used in a wide variety of automotive, electrical and consumer applications, including ignition system parts, radiator grilles, electrical switches, appliance and sensor housings, LEDs and technical fibers.

Base monomers, such as dimethyl terephthalate and PTA, are widely available with pricing dependent on broader polyester fiber and packaging resins market conditions.

Smaller volume specialty co-monomers for these products are typically supplied by a few companies.

Liquid crystal polymers (“LCP”), such as Vectra, are used in electrical and electronics applications and for precision parts with thin walls and complex shapes or on high-heat cookware application.

Fortron, a PPS product, is used in a wide variety of automotive and other applications, especially those requiring heat and/or chemical resistance, including fuel system parts, radiator pipes and halogen lamp housings, and often replaces metal in these demanding applications.

Other possible application fields include non-woven filtration devices such as coal fired power plants.

Fortron is manufactured by Fortron Industries LLC, Advanced Engineered Materials’ 50-50 venture with Kureha Corporation of Japan.

Facilities Advanced Engineered Materials has polymerization, compounding and research and technology centers in Germany, Brazil and the United States.

On November 29, 2006, Advanced Engineered Materials reached a settlement with the Frankfurt, Germany, Airport (“Fraport”) to relocate its Kelsterbach, Germany, business, resolving several years of legal disputes related to the planned Frankfurt airport expansion.

The final settlement agreement was signed on June 12, 2007.

As a result of the settlement, Advanced Engineered Materials will transition its operations from Kelsterbach to the Hoechst Industrial Park in the Rhine Main area by 2011.

See Note 29 to the consolidated financial statements for further information.

Markets The following table illustrates the destination of the net sales of the Advanced Engineered Materials segment by geographic region for the years ended December 31, 2007, 2006 and 2005.

Net Sales to External Customers by Destination — Advanced Engineered Materials

Advanced Engineered Materials’ sales in the Asian market are made mainly through its ventures, Polyplastics, KEPCO and Fortron Industries, which are accounted for under the equity method and therefore not included in Advanced Engineered Materials’ consolidated net sales.

If Advanced Engineered Materials’ portion of the sales made by these ventures were included in the chart above, the percentage of sales sold in Asia/Australia would be substantially higher.

A number of Advanced Engineered Materials’ POM customers, particularly in the appliance,

estimated at reporting dates prior to that time.

The compensation expense recognized each period should be based on the most recent estimated value.

The Company’s recording of compensation expenses prior to fiscal 2006 for these grants were an estimate based on grant date fair value.

Fiscal 2006 includes the effect of the change for that year.

The effect on years prior to fiscal 2006 was not material.

Further, in accordance with EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock,” the Company classifies these non-employee awards as liabilities at fair value upon vesting, with changes in fair value reported in earnings until these awards are exercised or forfeited.

The Company’s net income for the years ended September 30, 2007, September 30, 2006, and September 30, 2005 includes $7.0 million, $9.7 million, and $2.1 million, respectively, of compensation costs and $2.7 million, $3.7 million, and $804,000, respectively, net of income tax benefits related to option grants to its independent contractor Financial Advisors.

The fair value of each fixed option grant awarded to an independent contractor Financial Advisor is estimated on the date of grant and periodically revalued using the Black-Scholes option pricing model with the following weighted average assumptions used for fiscal years ended 2007, 2006, and 2005:

The dividend yield assumption is based on the Company’s current declared dividend as a percentage of the stock price.

The expected volatility assumption for the current period and fiscal 2006 is based on the Company’s historical stock price and is a weighted average combining (1) the volatility of the most recent year, (2) the volatility of the most recent time period equal to the expected lives assumption, and (3) the annualized volatility of the price of the Company’s stock since the late 1980’s.

The expected volatility used by the Company in fiscal 2005 was based on the annualized volatility of the price of the Company’s stock since the late 1980’s.

The risk-free interest rate assumption is based on the U. S.  Treasury yield curve in effect at each point in time the options are valued.

The expected lives assumption is based on the difference between the option’s vesting date plus 90 days (the average exercise period) and the date of the current reporting period.

A summary of option activity of the Company's fixed stock option plans under which awards are granted to its independent contractor Financial Advisors for the year ended September 30, 2007 is presented below:

As of September 30, 2007, there was $7.7 million of total unrecognized compensation cost related to unvested stock options granted to its independent contractor Financial Advisors based on estimated fair value at that date.

These costs are expected to be recognized over a weighted average period of approximately 2.3 years.

The weighted average grant date fair value of stock options granted under these plans during the years ended September 30, 2007, September 30, 2006 and September 30, 2005 was $9.70 per share, $11.87 per share and $9.51 per share, respectively.

The total intrinsic value of stock options exercised for these plans during the years ended September 30, 2007, September 30, 2006 and September 30, 2005 was $6.1 million, $5.6 million and $2.7 million, respectively.

The total estimated fair value of stock options vested for these plans during the years ended September 30, 2007, September 30, 2006 and September 30, 2005 was $6.2 million, $4.1 million and $3.5 million, respectively.

Cash received from stock option exercises for these plans for the year ended September 30, 2007 was $5.9 million.

There were no actual tax benefits realized for the tax deductions from option exercise of awards to its independent contractor Financial Advisors for the year ended September 30, 2007.

Answer: 3900000.0


Question: What's the total amount of Subtotal analog signal processing without those Subtotal analog signal processing smaller than 500000, in 2014?

def solution():
    # Define variables name and value
    converters = 1285368
    amplifiers_radio_frequency = 806975

    # Do math calculation to get the answer
    answer = converters + amplifiers_radio_frequency

    return answer

The year-to-year increase in communications end market revenue in fiscal 2014 was primarily a result of increased wireless base station deployment activity and, to a lesser extent, an increase in revenue as a result of the Acquisition.

Industrial end market revenue increased year-over-year in fiscal 2014 as compared to fiscal 2013 as a result of an increase in demand in this end market, which was most significant for products sold into the instrumentation and automation sectors and, to a lesser extent, an increase in revenue as a result of the Acquisition.

The year-to-year increase in automotive end market revenue in fiscal 2014 was primarily a result of increasing electronic content in vehicles and higher demand for new vehicles.

The year-toyear decrease in revenue in the consumer end market in fiscal 2014 was primarily the result of the sale of our microphone product line in the fourth quarter of fiscal 2013.

The year-to-year decrease in revenue in the industrial and consumer end markets in fiscal 2013 was primarily the result of a weak global economic environment and one less week of operations in fiscal 2013 as compared to fiscal 2012.

Automotive end market revenue increased in fiscal 2013 primarily as a result of increasing electronic content in vehicles.

Revenue Trends by Product Type The following table summarizes revenue by product categories.

The categorization of our products into broad categories is based on the characteristics of the individual products, the specification of the products and in some cases the specific uses that certain products have within applications.

The categorization of products into categories is therefore subject to judgment in some cases and can vary over time.

In instances where products move between product categories, we reclassify the amounts in the product categories for all prior periods.

Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each product category

The sum of the individual percentages does not equal the total due to rounding.

The year-to-year increase in total revenue in fiscal 2014 as compared to fiscal 2013 was the result of improving demand across most product type categories and the result of the Acquisition, which was partially offset by declines in the other analog product category, primarily as a result of the sale of our microphone product line in the fourth quarter of fiscal 2013.

The year-to-year decrease in total revenue in fiscal 2013 as compared to fiscal 2012 was the result of one less week of operations in fiscal 2013 as compared to fiscal 2012 and a broad-based decrease in demand across most product type categories.

Revenue Trends by Geographic Region Revenue by geographic region, based upon the primary location of our customers' design activity for its products, for fiscal 2014, 2013 and 2012 was as follows.

ANALOG DEVICES, INC.  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

|Stock Options|2014|2013|2012|
|Options granted (in thousands)|2,240|2,407|2,456|
|Weighted-average exercise price|$51.52|$46.40|$39.58|
|Weighted-average grant-date fair value|$8.74|$7.38|$7.37|
|Assumptions:||||
|Weighted-average expected volatility|24.9%|24.6%|28.4%|
|Weighted-average expected term (in years)|5.3|5.4|5.3|
|Weighted-average risk-free interest rate|1.7%|1.0%|1.1%|
|Weighted-average expected dividend yield|2.9%|2.9%|3.0%|

As it relates to our market-based restricted stock units, the Company utilizes the Monte Carlo simulation valuation model to value these awards.

The Monte Carlo simulation model utilizes multiple input variables that determine the probability of satisfying the performance conditions stipulated in the award grant and calculates the fair market value for the market-based restricted stock units granted.

The Monte Carlo simulation model also uses stock price volatility and other variables to estimate the probability of satisfying the performance conditions, including the possibility that the market condition may not be satisfied, and the resulting fair value of the award.

Information pertaining to the Company's market-based restricted stock units and the related estimated assumptions used to calculate the fair value of market-based restricted stock units granted using the Monte Carlo simulation model is as follows:

|Market-based Restricted Stock Units|2014|
|Units granted (in thousands)|86|
|Grant-date fair value|$50.79|
|Assumptions:||
|Historical stock price volatility|23.2%|
|Risk-free interest rate|0.8%|
|Expected dividend yield|2.8%|

Market-based restricted stock units were not granted during fiscal 2013 or 2012.

Expected volatility — The Company is responsible for estimating volatility and has considered a number of factors, including third-party estimates.

The Company currently believes that the exclusive use of implied volatility results in the best estimate of the grant-date fair value of employee stock options because it reflects the market’s current expectations of future volatility.

In evaluating the appropriateness of exclusively relying on implied volatility, the Company concluded that: (1) options in the Company’s common stock are actively traded with sufficient volume on several exchanges; (2) the market prices of both the traded options and the underlying shares are measured at a similar point in time to each other and on a date close to the grant date of the employee share options; (3) the traded options have exercise prices that are both near-the-money and close to the exercise price of the employee share options; and (4) the remaining maturities of the traded options used to estimate volatility are at least one year.

Expected term — The Company uses historical employee exercise and option expiration data to estimate the expected term assumption for the Black-Scholes grant-date valuation.

The Company believes that this historical data is currently the best estimate of the expected term of a new option, and that generally its employees exhibit similar exercise behavior.

Risk-free interest rate — The yield on zero-coupon U. S.  Treasury securities for a period that is commensurate with the expected term assumption is used as the risk-free interest rate.

Expected dividend yield — Expected dividend yield is calculated by annualizing the cash dividend declared by the Company’s Board of Directors for the current quarter and dividing that result by the closing stock price on the date of grant.

Until such time as the Company’s Board of Directors declares a cash dividend for an amount that is different from the current quarter’s cash dividend, the current dividend will be used in deriving this assumption.

Cash dividends are not paid on options, restricted stock or restricted stock units.

an adverse development with respect to one claim in 2008 and favorable developments in three cases in 2009.

Other costs were also lower in 2009 compared to 2008, driven by a decrease in expenses for freight and property damages, employee travel, and utilities.

In addition, higher bad debt expense in 2008 due to the uncertain impact of the recessionary economy drove a favorable year-over-year comparison.

Conversely, an additional expense of $30 million related to a transaction with Pacer International, Inc.  and higher property taxes partially offset lower costs in 2009.

Other costs were higher in 2008 compared to 2007 due to an increase in bad debts, state and local taxes, loss and damage expenses, utility costs, and other miscellaneous expenses totaling $122 million.

Conversely, personal injury costs (including asbestos-related claims) were $8 million lower in 2008 compared to 2007.

The reduction reflects improvements in our safety experience and lower estimated costs to resolve claims as indicated in the actuarial studies of our personal injury expense and annual reviews of asbestos-related claims in both 2008 and 2007.

The year-over-year comparison also includes the negative impact of adverse development associated with one claim in 2008.

In addition, environmental and toxic tort expenses were $7 million lower in 2008 compared to 2007.

Answer: 2092343.0


Question: What is the sum of the Finance — Finance Companies in the sections where Finance — Finance Companies is positive? (in million)

def solution():
    # Define variables name and value
    finance_companies_positive = [265.2, 9.0, 18.7, 255.5]

    # Do math calculation to get the answer
    answer = sum(finance_companies_positive)

    return answer

Directors and Executive Officers of the Registrant.

Pursuant to Section 406 of the Sarbanes-Oxley Act of 2002, we have adopted a Code of Ethics for Senior Financial Officers that applies to our principal executive officer and principal financial officer, principal accounting officer and controller, and other persons performing similar functions.

Our Code of Ethics for Senior Financial Officers is publicly available on our website at www.

We intend to satisfy the disclosure requirement under Item 5.05 of Current Report on Form 8-K regarding an amendment to, or waiver from, a provision of this code by posting such information on our website, at the address specified above.

The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.

The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

We maintain a number of equity compensation plans for employees, officers, directors and others whose efforts contribute to our success.

The table below sets forth certain information as our fiscal year ended September 24, 2005 regarding the shares of our common stock available for grant or granted under stock option plans that (i) were approved by our stockholders, and (ii) were not approved by our stockholders.

The number of securities and the exercise price of the outstanding securities have been adjusted to reflect our two-for-one stock split effected on November 30, 2005.

|Plan Category|Number Of Securities To Be Issued Upon ExerciseOf Outstanding Options, Warrants And Rights (a)|Weighted-Average Exercise Price Of Outstanding Options, Warrants And Rights (b)|Number Of Securities Remaining Available For Future Issuance Under EquityCompensation Plans (excluding securities reflected in column (a)) (c)|
|Equity compensation plans approved by security holders -1|3,841,008|$7.84|1,016,520|
|Equity compensation plans not approved by security holders -2|863,604|$6.44|0|
|Total|4,704,612|$7.58|1,016,520|

(1) Includes the following plans: 1986 Combination Stock Option Plan; Amended and Restated 1990 Non-employee Director Stock Option Plan; 1995 Combination Stock Option Plan; Amended and Restated 1999 Equity Incentive Plan; and 2000 Employee Stock Purchase Plan.

Also includes the following plans which we assumed in connection with our acquisition of Fluoroscan Imaging Systems in 1996: FluoroScan Imaging Systems, Inc.  1994 Amended and Restated Stock Incentive Plan and FluoroScan Imaging Systems, Inc.  1995 Stock Incentive Plan.

For a description of these plans, please refer to Footnote 5 contained in our consolidated financial statements.

Fixed Maturity Securities Available-for-Sale The following tables present our fixed maturity securities available-for-sale by industry category and the associated gross unrealized gains and losses, including other-than-temporary impairment losses reported in OCI, as of December 31, 2009 and 2008.

| | December 31, 2009|
| | Amortized cost| Gross unrealized gains| Gross unrealized losses| Carrying amount|
| |(in millions) |
|Finance — Banking|$4,288.5|$68.2|$480.4|$3,876.3|
|Finance — Brokerage|428.6|11.0|6.4|433.2|
|Finance — Finance Companies|265.2|9.0|18.7|255.5|
|Finance — Financial Other|535.6|26.0|8.6|553.0|
|Finance — Insurance|2,714.9|36.5|207.9|2,543.5|
|Finance — REITS|1,327.1|14.6|80.0|1,261.7|
|Industrial — Basic Industry|1,921.4|74.9|19.1|1,977.2|
|Industrial — Capital Goods|2,364.0|99.1|33.0|2,430.1|
|Industrial — Communications|2,761.6|174.3|21.8|2,914.1|
|Industrial — Consumer Cyclical|1,597.0|69.4|32.0|1,634.4|
|Industrial — Consumer Non-Cyclical|3,149.6|172.0|27.4|3,294.2|
|Industrial — Energy|1,933.3|108.3|19.2|2,022.4|
|Industrial — Other|700.0|22.8|20.0|702.8|
|Industrial — Technology|765.0|31.6|11.2|785.4|
|Industrial — Transportation|934.9|41.7|18.4|958.2|
|Utility — Electric|2,518.6|115.6|18.6|2,615.6|
|Utility — Natural Gas|1,086.2|66.0|7.4|1,144.8|
|Utility — Other|122.8|3.2|0.6|125.4|
|FDIC guaranteed|96.1|1.4|—|97.5|
|Government guaranteed|1,102.8|76.3|16.9|1,162.2|
|Total corporate securities|30,613.2|1,221.9|1,047.6|30,787.5|
|Residential pass-through securities|3,019.1|86.0|3.8|3,101.3|
|Commercial mortgage-backed securities|4,898.0|20.9|1,319.2|3,599.7|
|Residential collateralized mortgage obligations -1|1,198.9|13.5|114.9|1,097.5|
|Asset-backed securities — Home equity -2|487.1|—|173.1|314.0|
|Asset-backed securities — All other|1,308.1|21.1|15.5|1,313.7|
|Collateralized debt obligations — Credit|197.2|1.5|67.0|131.7|
|Collateralized debt obligations — CMBS|257.0|—|129.4|127.6|
|Collateralized debt obligations — Loans|101.4|—|21.4|80.0|
|Collateralized debt obligations — ABS -3|51.9|0.3|21.9|30.3|
|Total mortgage-backed and other asset-backed securities|11,518.7|143.3|1,866.2|9,795.8|
|U.S. Government and agencies|550.1|9.1|0.5|558.7|
|States and political subdivisions|2,008.7|53.4|13.5|2,048.6|
|Non-U.S. governments|421.1|42.4|1.1|462.4|
|Total fixed maturity securities, available-for-sale|$45,111.8|$1,470.1|$2,928.9|$43,653.0|

(1) Includes exposure to Alt-a mortgage loans with an amortized cost of $59.6 million, gross unrealized losses of $18.2 million, and a carrying amount of $41.4 million.

The Alt-a portfolio has a weighted average rating of BBB and 66% are 2005 and prior vintages.

(2) This exposure is all related to sub-prime mortgage loans.

(3) Includes exposure to sub-prime mortgage loans with an amortized cost of $27.4 million, gross unrealized gains of $0.3 million, gross unrealized losses of $17.9 million, and a carrying amount of $9.8 million.

Gross project expenses related to our Business Transformation Project, inclusive of pay-related expense, increased by $20.8 million in fiscal 2011 from fiscal 2010 and by $41.6 million in fiscal 2010 from fiscal 2009.

The increase in fiscal 2011 resulted from increased project spend including the initial stages of ramping up of our shared services center and a provision for severance resulting from the implementation of an involuntary severance plan.

The increase in fiscal 2010 resulted from only six months of activity being included in fiscal 2009, as the Business Transformation Project began in January 2009.

Provided the improvements needed in the underlying systems are obtained in the first half of fiscal 2012, we anticipate the software will be ready for its intended use in the second half of fiscal 2012, which will result in increased expense from both software amortization and deployment costs.

We will also incur increased costs from the ramp up of our shared services center, continuing costs for additional phases of our Business Transformation Project and information technology support costs.

We believe the increase in gross project expenses, including all pay-related expenses, related to the Business Transformation Project in fiscal 2012 as compared to fiscal 2011 will be approximately $175 million to $195 million.

We adjust the carrying values of our COLI policies to their cash surrender values on an ongoing basis.

The cash surrender values of these policies are largely based on the values of underlying investments, which through fiscal 2011 included publicly traded securities.

As a result, the cash surrender values of these policies fluctuated with changes in the market value of such securities.

The changes in the financial markets resulted in gains for these policies of $28.2 million in fiscal 2011, compared to gains for these policies of $21.6 million in fiscal 2010 and losses of $43.8 million in fiscal 2009.

Near the end of fiscal 2011, we reallocated all of our policies into low-risk, fixed-income securities and therefore we no longer expect significant volatility in operating income, net earnings and earnings per share in future periods related to these policies.

The provision for losses on receivables included within operating expenses decreased by $39.7 million in fiscal 2010 over fiscal 2009.

The decrease in our provision for losses on receivables in fiscal 2010 reflects fewer customer accounts exceeding our threshold for write-off in fiscal 2010 as compared to fiscal 2009.

Customer accounts written off, net of recoveries, were $37.8 million, or 0.10% of sales, $34.3 million, or 0.10% of sales, and $71.9 million, or 0.20% of sales, for fiscal 2011, 2010 and 2009, respectively.

Our provision for losses on receivables will fluctuate with general market conditions, as well as the circumstances of our customers.

Net Earnings Net earnings for fiscal 2011 decreased 2.4% over the comparable prior year period.

After adjusting for the estimated impact of the 53rd week in fiscal 2010, the decrease would have been 0.3%.

This adjusted decrease was primarily due to the factors discussed above and an increase in the effective tax rate.

The effective tax rate for fiscal 2011 was 36.96%, compared to an effective tax rate of 36.20% for fiscal 2010.

The difference between the tax rates for the two periods resulted largely from the one-time reversal of interest accruals for tax contingencies related to our settlement with the Internal Revenue Service (IRS) in the first quarter of fiscal 2010.

Net earnings increased 11.7% in fiscal 2010 from fiscal 2009.

After adjusting for the estimated impact of the 53rd week in fiscal 2010, the increase would have been 9.5%.

This adjusted increase was primarily due to a reduction in the effective income tax rate, as well as the factors discussed above.

The effective tax rate for fiscal 2010 was 36.20%, compared to an effective tax rate of 40.37% for fiscal 2009.

Set forth below is a reconciliation of actual net earnings to adjusted net earnings for the periods presented (see further discussion at “Impact of 53-week fiscal year in Fiscal 2010” above):

||2011|2010 (53 Weeks)| 2009|
|| (In thousands)|
|Net earnings for the 53/52 week periods|$1,152,030|$1,179,983|$1,055,948|
|Estimated net earnings for the additional week in fiscal 2010|—|24,127|—|
|Adjusted net earnings|$1,152,030|$1,155,856|$1,055,948|
|Actual percentage (decrease) increase|-2.4%|11.7%||
|Adjusted percentage (decrease) increase|-0.3%|9.5%||

The effective tax rate of 36.96% for fiscal 2011 was favorably impacted primarily by two items.

First, we recorded a tax benefit of approximately $17.0 million for the reversal of valuation allowances previously recorded on state net operating loss carryforwards.

Second, we adjust the carrying values of our COLI policies to their cash surrender values.

The gain of $28.2 million recorded in fiscal 2011 was primarily nontaxable for income tax purposes, and had the impact of decreasing income tax expense for the period by $11.1 million.

Partially offsetting these favorable impacts was the recording of $9.3 million in tax and interest related to various federal, foreign and state uncertain tax positions.

The effective tax rate of 36.20% for fiscal 2010 was favorably impacted primarily by two items.

First, we recorded an income tax benefit of approximately $29.0 million resulting from the one-time reversal of a previously accrued liability related to the settlement with the IRS (See “Liquidity and Capital Resources, Other Considerations, BSCC Cooperative Structure” for additional discussion).

Second, the gain of $21.6 million recorded to adjust the carrying value of COLI policies to their cash surrender values in fiscal 2010 was non-taxable for income tax purposes, and had the impact of decreasing income tax expense for the period by $8.3 million.

The effective tax rate of 40.37% for fiscal 2009 was unfavorably impacted primarily by two factors.

First, we recorded tax adjustments related to federal and state uncertain tax positions of $31.0 million.

Second, the loss of $43.8 million recorded to adjust the carrying value of COLI policies to their cash surrender values in fiscal 2009 was non-deductible for income tax purposes, and had the impact of increasing income tax expense for

Answer: 548.4